DLX-105
Product Specifications
Target
Interleukin, TNF, IFNAR
Related Pathways
Apoptosis, Immunology/Inflammation
Bioactivity
DLX-105 is a human monoclonal antibody (mAb) that targets TNFSF2/TNFa. It reduces epidermal thickness and the expression of K16 and Ki67 in the skin. Additionally, DLX-105 downregulates mRNA levels of IL-17, TNF-α, IL-23p19, IL-12p40, and IFN-γ. This compound is useful for psoriasis research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog